Fair Richard A. 4/A
4/A · BELLICUM PHARMACEUTICALS, INC · Filed Aug 18, 2021
Insider Transaction Report
Form 4/AAmended
Fair Richard A.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2021-08-16+265,000→ 265,000 totalExercise: $2.88From: 2022-08-16Exp: 2031-08-16→ Common Stock (265,000 underlying)
Footnotes (1)
- [F1]This amendment is being filed to correct the typographical error in the exercise price of the stock option on the original Form 4 filed with the SEC on August 16, 2021